VasQ(动静脉瘘外部支撑植入物)的上市后研究
上市后监测、前瞻性、多中心、随机、对照研究评估 VasQ 的预期用途性能。
VasQ is an external support implant for arteriovenous fistulas created for dialysis access.
This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms:
- Treatment arm: End to side fistula supported with VasQ
- Control: Standard of care end to side fistula
研究概览
详细说明
Structure
This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms:
- Treatment arm: End to side fistula supported with VasQ
- Control: Standard of care end to side fistula
Duration The primary endpoint is defined at 6 month post index procedure of fistula creation. Patients will be further followed up to 12 months post index procedure.
Main study question What is the magnitude of benefit of the VasQ device with regard to time to achieving a clinically functional AVF as compared to a comparable contemporary standard of care cohort?
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Galit Itzhaki
- 电话号码:+972-3-6344246
- 邮箱:galit@laminatemedical.com
学习地点
-
-
California
-
Long Beach、California、美国、90706
- 招聘中
- Fresenius Vascular Care Long Beach
-
接触:
- Deann Helton
- 电话号码:562-888-8961
- 邮箱:Deann.Helton@azuracare.com
-
首席研究员:
- Anthony Becker, MD
-
-
Florida
-
Sarasota、Florida、美国、34239
- 招聘中
- Sarasota Memorial Health Care System
-
首席研究员:
- Jason Wagner, MD
-
接触:
- Kaitlyn Meek, RN
- 电话号码:941-917-7109
- 邮箱:ResearchInstitute@smh.com
-
-
Georgia
-
Atlanta、Georgia、美国、30303
- 招聘中
- Grady Memorial Hospital
-
首席研究员:
- Christopher Ramos, MD
-
接触:
- Ronnie Adams
- 电话号码:404-251-8984
- 邮箱:rwadam2@emory.edu
-
Decatur、Georgia、美国、30033
- 招聘中
- Atlanta VA Medical Center
-
首席研究员:
- Olamide Alabi, MD
-
接触:
- Adriana Gutrierrez Yllu
- 电话号码:404-729-6350
- 邮箱:Adriana.Gutierrezyllu@va.gov
-
接触:
- Maddie Sancheti
- 电话号码:404-321-6111
- 邮箱:madhur.sancheti@va.gov
-
-
Louisiana
-
New Orleans、Louisiana、美国、70121
- 招聘中
- Ochsner Clinic Foundation
-
接触:
- Shannon Williams
- 电话号码:504-842-6487
- 邮箱:slwilliams@ochsner.org
-
首席研究员:
- Waldemar Sternbergh, MD
-
-
Massachusetts
-
Boston、Massachusetts、美国、02115
- 招聘中
- Brigham and Women's Hospital
-
接触:
- Navya Kotturu
- 电话号码:617-525-8555
- 邮箱:nkotturu@bwh.harvard.edu
-
接触:
- Danielle Montano
- 电话号码:617-525-8555
- 邮箱:dmontano2@bwh.harvard.edu
-
首席研究员:
- Mohamad Hussain, MD
-
-
Mississippi
-
Greenwood、Mississippi、美国、38930
- 招聘中
- Greenwood Leflore Hospital
-
接触:
- Kimberly McMillian
- 电话号码:662-453-4641
- 邮箱:kmcmillian@glh.org
-
首席研究员:
- John F Lucas, MD
-
-
Nevada
-
Las Vegas、Nevada、美国、99128
- 主动,不招人
- Azura Surgery Center Las Vegas
-
-
South Carolina
-
Columbia、South Carolina、美国、29203
- 招聘中
- Fresenius Vascular Care Columbia
-
接触:
- Alicia Phillips-Pough
- 电话号码:803-252-3373
- 邮箱:alicia.phillips-pough@azuracare.com
-
接触:
- Tami Hardwick
- 电话号码:803-252-3373
- 邮箱:tami.hardwick@azuracare.com
-
首席研究员:
- Dion Franga, MD
-
-
Tennessee
-
Memphis、Tennessee、美国、38115
- 尚未招聘
- James E. Gardner MD, P.C.
-
接触:
- Hannah Touliatos
- 电话号码:901-604-0345
- 邮箱:hannahgardner3@gmail.com
-
首席研究员:
- James Gardner, MD
-
Nashville、Tennessee、美国、37232
- 招聘中
- Vanderbilt University Medical Center
-
接触:
- Stephen R Gannon
- 电话号码:615-936-6809
- 邮箱:stephen.r.gannon@vumc.org
-
首席研究员:
- Robert Shahverdyan, MD
-
-
Texas
-
Houston、Texas、美国、77030
- 招聘中
- Houston Methodist Hospital
-
首席研究员:
- Eric Peden, MD
-
接触:
- Abhiraj Sinha
- 电话号码:404-251-8984
- 邮箱:asinha@houstonmethodist.org
-
-
Virginia
-
Roanoke、Virginia、美国、24014
- 招聘中
- Fairlawn Surgery Center
-
首席研究员:
- Ryan Evans, MD
-
接触:
- Aleisha Umber, RN
- 电话号码:540-904-6170
- 邮箱:AUMBER@FSCMED.COM
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients who are candidates for the creation of a new radiocephalic or brachiocephalic end-to-side surgical AV fistula for dialysis access (per VasQ IFU and investigator clinical judgment) and consent to take part in the study.
- Male and non-pregnant female participants.
- Age 18-80 years
- Patients willing and able (physically and geographically) to attend follow up visits over a period of 12 months.
Exclusion Criteria:
- Index procedure being a revision surgery of an existing fistula.
- Significantly stenotic target vein on the side of surgery (≥50%) as diagnosed on preoperative ultrasound. (Scan should include the full length of the expected fistula outflow, starting at the planned anastomosis site)
- Unusual anatomy or vessel dimensions (observed on pre-operative ultrasound or intraoperatively) and which preclude adequate fit of the VasQ.
- Known central venous stenosis or obstruction on the side of surgery.
- Pre-existing stents or stent grafts in the access circuit.
- Planned subsequent fistula superficialization procedure.
- Known coagulation disorder.
- Known allergy to nitinol.
- Expected kidney transplant within 12 months of enrollment.
- Inability to give consent and/or comply with the study follow up schedule.
- Insufficient or borderline life expectancy to allow for completion of study procedures and follow-up (12 Months).
- Participation in another interventional study that in the judgment of the investigator could confound study results.
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:End to side fistula supported with VasQ
Patients receiving an end to side arteriovenous fistula, supported by VasQ, for fistula access |
External support implant for the arteriovenous fistula End to side fistula creation in the arm for dialysis vascular access |
|
有源比较器:Standard of care end to side fistula
Patients receiving an end to side arteriovenous fistula, for fistula access |
End to side fistula creation in the arm for dialysis vascular access |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Fistula functional success
大体时间:6 months
|
The time, in days, to the first day of a 28-day period in which the study fistula was able to be cannulated with two dialysis needles for at least 75% of dialysis sessions to achieve the prescribed dialysis |
6 months
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Safety - vascular access related complications
大体时间:1 year
|
Comparable rate of access related complications (including major reintervention and cannulation related complications) |
1 year
|
合作者和调查者
调查人员
- 首席研究员:John F Lucas III, MD FACS FSVS、Greenwood Leflore Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- CD0261
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.